Gordana Vunjak-Novakovic, PhD

Overview

Academic Appointments

  • Mikati Foundation Professor of Biomedical Engineering and Professor of Medical Sciences (in Medicine)

Administrative Titles

  • University Professor

Gordana Vunjak-Novakovic holds the title of University Professor, Columbia University’s highest rank reserved for a small number of faculty who have made important contributions to their field of study, and serve the university as a whole. She is a leading expert in engineering of human tissues for regenerative medicine and modeling of disease. With over 36,000 citations and h=109, she is one of the most highly cited individuals of all times, in all disciplines. With her students, she founded four biotech companies, all based in New York City. Among her many distinctions, she is a member of the Academia Europaea, National Academy of Engineering, National Academy of Medicine, and National Academy of Inventors.

Credentials & Experience

Education & Training

  • PhD, Chemical Engineering, University of Belgrade,Yugoslavia
  • Fellowship: Massachusetts Institute of Technology

Honors & Awards

2017               Robert A. Pritzker Award for 2017, Biomedical Engineering Society

2017               NIBIB National Advisory Council speaker, NIH, January 24, 2017.

2017               Doctorate in Science Honoris Causa, University of Novi Sad, Serbia

2015-2020      Bioengineering Peer Committee, National Academy of Engineering

2016-2017      Chair, College of Fellows, American Institute for Medical and Biological Engineering (AIBME)

2016-             Board of Directors, American Institute for Medical and Biological Engineering (AIBME)

2016               Award of the Materials Research Society for Lasting and Outstanding Contribution to Material Science and Engineering

2014               National Academy of Inventors       

2014               American Association for the Advancement of Science (AAAS)

2014               National Academy of Medicine

2014               Foreign Policy’s 100 Leading Global Thinkers of 2014     

2013-              National Academy of Engineering, Executive Committee, Section for Bioengineering

2013-2016      National Academy of Engineering, Fritz J and Dolores H Russ Prize Committee

2013               Founding Class, International Fellows of Tissue Engineering and Regenerative Medicine

2012               National Academy of Engineering

2012               Academia Europea, Cell and Development Biology section

2012               Serbian Academy of Sciences and Arts

2012               Serbian National Academy of Engineering

2012               Fellow, Biomedical Engineering Society (BMES)

2010               Clemson award of the Society of Biomaterials “for significant contributions to    

                       the literature on the science or technology of biomaterials”

2009 -            New York Academy of Sciences

2008               Hall of Fame, Women in Technology International (one of 5 leaders in science and

                       technology in 2008)

2008 -             US Section Head, Musculoskeletal Repair & Regeneration Section, Faculty 1000 of Medicine

2007               Director’s lecture, NIH, October 17, 2007; the first woman engineer to receive this

                      distinction

2006               NASA Award for a patent “BMP-2, BMP-12, and BMP-13 Modulate in Vitro

                       Development of Engineered Cartilage”

2005               The Association of Orthopedic Research, Switzerland; team award “for the best

                       science in orthopaedics” (with Meinel, Ziechner. Fajardo, and Kaplan)

2004               Outstanding Performance Medal, World Congress of in vitro Biology.

2004               Space Act Award, NASA, for patent describing bioengineering of anterior cruciate

                       ligaments (US patent 6,287,340, issued September 11, 2001)

2004 -            Faculty of 1000 Medicine, Regenerative Medicine Section

2004               Space Act Award, NASA, for patent describing gene transfer of a growth factor to

                       enhance tissue engineering of cartilage

2000 -            American Institute for Medical and Biological Engineering (AIMBE), Fellow

1997               Medal of recognition, Centennial of the Serbian Chemical Society, Belgrade YU

1996 – 1997   Space study of cartilage tissue engineering aboard “Mir”, in collaboration with NASA

                       Johnson Space Center (co-lead of the 13-member team, with LE Freed); the longest

                        cell experiment ever conducted in space; study reported in PNAS)

1987               Serbian Academy of Sciences and Arts, Biomass Committee

1980               City of Belgrade award for the best PhD thesis in engineering

1975               Belgrade Chamber of Commerce award for the best MS thesis in engineering

Research

Grants

UG3 EB025765 (Vunjak-Novakovic)                                              9/1/17-6/30/22                                

Multi-tissue platform for modeling systemic pathologies                                                              

2R01 DE016525 (Vunjak-Novakovic)                                            4/1/13 – 3/31/18                 

Craniofacial Tissue Engineering

2R01 HL076485-07 (Vunjak-Novakovic)                                        4/17/13 – 4/01/18                                                                                

Vascularized cardiac muscle

R01 HL120046-01 (Vunjak-Novakovic and Snoeck MPI)                        8/7/13 – 5/31/18                 =

Bioengineering a chimeric human lung

U01HL134760 (Snoeck and Vunjak-Novakovic MPI)                   9/20/16-9/19/23                  

Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis  

U01HL134760-S3 (Snoeck and Vunjak-Novakovic MPI)             10/1/17-9/30/18                  

Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis 

UH3 EB17103 (Vunjak-Novakovic)                                                7/1/14-12/31/17                  

Integrated heart-liver-vascular systems for drug testing in human health and disease

P41 EB002520 (Kaplan PG; role:Associated PD)             08/1/14 – 07/31/19          

Tissue Engineering Resource Center – Bioreactor Core

NYSTEM IIRP (Vunjak-Novakovic)                                     7/1/17-6/30/20                                

Optogenetic regulation of cardiac arrhythmia using patient-derived IPS cell models                

C030291 NYSTEM (Vunjak-Novakovic)                             07/01/16 – 06/30/21                      

Columbia training program in stem cell research

3UH3EB017103-05S2 (Vunjak-Novakovic)                                  7/1/16-12/31//17                

Integrated cardiac and bone tissue chip for rare disease research

3UH3EB017103-05S1 (Vunjak-Novakovic)                                  7/1/16-12/31/17             

Tissue chip for integrating testis as a missing organ                                                       

3UH3EB017103-04S2                                                                    7/1/15-12/31/17                  

Integrated heart-liver-vascular systems for drug testing in human health and disease

NSF16478 Engineering Resource Center (Bishop)                        9/1/17 – 7/31/22            

Nanosystems Engineering Research Center for Directed Multiscale                               

Assembly of Cellular Metamaterials with Nanoscale Precision: CELL-MET                    

Role: Subcontract PI

Coulter Foundation (Vunjak-Novakovic)                                          8/1/14 – 5/31/15                 

A stem cell therapy to reduce morbidity and mortality from graft-vs-host-disease in bone marrow transplant patients

R41HL129754 (Spotnitz)                                                    

Advanced cannula development for coronary sinus access           9/1/17-8/31/18                                

Role: Collaborator                 

DOD_W81XWH (Fine)

Cardiomyocyte chirality defects in congenital heart disease         05/01/17 – 10/30/18                      

Role: Co-I

Lisa and Mark Schwartz Program to Reverse Heart Failure            1/1/13 – 12/31/17               

(Vunjak-Novakovic: Scientific Director)     

T32 HL120826 (Marks)                                                                   1/1/14 – 12/31/18               

Training in cardiovascular translational research.

Role: mentor

T32 (Hardy)                                                                           1/1/2011 – 12/31/16         

Cardiology-Surgery training grant

Role: mentor

T32 (Ateshian)                                                                                  1/1/2012 – 12/31/17         

Multidisciplinary Engineering Training in Musculoskeletal Research

Role: mentor

T32 (Bickers)                                                                         1/1/2012 – 12/31/17         

Genetic Mechanism in Skin Disease Training Grant          

Role: mentor

T32 (Shelanski)                                                                                 1/1/2012 – 12/31/17         

Medical Scientist Training Program

Role: mentor

MODELING, PATHOGENESIS AND TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS (Federal Gov)

Sep 20 2016 - May 31 2023

CHARACTERIZATION OF CARDIAC BEHAVIOR AS A FUNCTION OF TOPOLOGY (Federal Gov)

Sep 15 2016 - Sep 14 2019

BIOLOGICALLY INSPIRED ENGINEERING OF HIERARCHICAL VASCULAR NETWORKS (Federal Gov)

Feb 10 2012 - Feb 9 2015

TRACKING STEM CELLS IN ENGINEERED TISSUE AND ORGANS IN VIVO AND IN REAL TIME (Federal Gov)

Sep 15 2009 - Aug 31 2014

COLLABORATIVE EFFORT IN STEM CELL BIOLOGY (Private)

Jul 1 2010 - Jun 30 2014

ENGINEERING OF VASCULARIZED BONE (Federal Gov)

Sep 25 2009 - May 31 2014

REGENERATION OF CLINICALLY RELEVANT OROFACIAL TISSUES IN PRE-CLINICAL MODELS (Federal Gov)

Sep 25 2009 - Aug 31 2013

Selected Publications

With over 36,000 citations and h=109, Dr Vunjak-Novakovic is one of the most cited individuals of all tims, in all disciplines.

The complete list of publiacations is avaliable on the link pasted below.